miR-210 from CML exosomes has also been shown to interact with the target gene Ephrin-A3 and play a vital role in angiogenesis and vascular endothelial growth factor (VEGF) signaling [101]. This evidence concerns the gene VEGFA and chronic myelogenous leukemia, BCR-ABL1 positive.